Clinical Trial Update: Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules [Phase 2, Phase 3]

View source ↗

Summary

The trial evaluated therapeutic equivalence between OsvaRen tablets and OsvaRen granules in hyperphosphatemia associated with chronic kidney disease, across Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• OsvaRen (sevelamer)

Snippet

Sponsor: Fresenius Medical Care Deutschland GmbH | Conditions: Hyperphosphatemia, Chronic Kidney Disease | Phase 2, Phase 3 | Status: COMPLETED